BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10598584)

  • 1. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements.
    Nelson CC; Hendy SC; Shukin RJ; Cheng H; Bruchovsky N; Koop BF; Rennie PS
    Mol Endocrinol; 1999 Dec; 13(12):2090-107. PubMed ID: 10598584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.
    Verrijdt G; Haelens A; Schoenmakers E; Rombauts W; Claessens F
    Biochem J; 2002 Jan; 361(Pt 1):97-103. PubMed ID: 11742533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.
    Haelens A; Verrijdt G; Callewaert L; Christiaens V; Schauwaers K; Peeters B; Rombauts W; Claessens F
    Biochem J; 2003 Jan; 369(Pt 1):141-51. PubMed ID: 12350223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.
    Schoenmakers E; Alen P; Verrijdt G; Peeters B; Verhoeven G; Rombauts W; Claessens F
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):515-21. PubMed ID: 10417312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
    Zhang S; Liang X; Danielsen M
    Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.
    Rennie PS; Bruchovsky N; Leco KJ; Sheppard PC; McQueen SA; Cheng H; Snoek R; Hamel A; Bock ME; MacDonald BS
    Mol Endocrinol; 1993 Jan; 7(1):23-36. PubMed ID: 8446105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor.
    Wan Y; Coxe KK; Thackray VG; Housley PR; Nordeen SK
    Mol Endocrinol; 2001 Jan; 15(1):17-31. PubMed ID: 11145736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The constitution of a progesterone response element.
    Lieberman BA; Bona BJ; Edwards DP; Nordeen SK
    Mol Endocrinol; 1993 Apr; 7(4):515-27. PubMed ID: 8388996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
    Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
    Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells.
    Boonyaratanakornkit V; Melvin V; Prendergast P; Altmann M; Ronfani L; Bianchi ME; Taraseviciene L; Nordeen SK; Allegretto EA; Edwards DP
    Mol Cell Biol; 1998 Aug; 18(8):4471-87. PubMed ID: 9671457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
    Govindan MV
    Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation.
    Rundlett SE; Miesfeld RL
    Mol Cell Endocrinol; 1995 Mar; 109(1):1-10. PubMed ID: 7789609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding.
    Brodie J; McEwan IJ
    J Mol Endocrinol; 2005 Jun; 34(3):603-15. PubMed ID: 15956332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.
    Whitacre DC; Karnas KJ; Miesfeld RL
    Endocrine; 2001 Jun; 15(1):111-8. PubMed ID: 11572317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses.
    Schoenmakers E; Verrijdt G; Peeters B; Verhoeven G; Rombauts W; Claessens F
    J Biol Chem; 2000 Apr; 275(16):12290-7. PubMed ID: 10766868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear extracts enhance the interaction of fusion proteins containing the DNA-binding domain of the androgen and glucocorticoid receptor with androgen and glucocorticoid response elements.
    De Vos P; Claessens F; Celis L; Peeters B; Rombauts W; Heyns W; Verhoeven G
    J Steroid Biochem Mol Biol; 1994 Mar; 48(4):317-23. PubMed ID: 8142310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element.
    Verrijdt G; Schoenmakers E; Alen P; Haelens A; Peeters B; Rombauts W; Claessens F
    Mol Endocrinol; 1999 Sep; 13(9):1558-70. PubMed ID: 10478846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
    Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
    Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
    Wang D; Simons SS
    Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the rules of engagement of androgen and glucocorticoid receptors.
    Claessens F; Joniau S; Helsen C
    Cell Mol Life Sci; 2017 Jun; 74(12):2217-2228. PubMed ID: 28168446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.